In contrast, miR-184 has demonstrated downregulation in SCLC and acts as a tumor suppressive miRNA as it represses endothelial PAS domain protein 1 (EPAS1)/HIF-2α leading to β-catenin activation [98]. Here, EPAS1 is linked to neoplasm.